Sanofi to acquire Origimm Biotechnology, gaining therapeutic acne vaccine candidate
Sanofi will acquire Origimm Biotechnology GmbH, an Austrian privately-owned biotech developing a therapeutic vaccine for acne.
Archives for December 1, 2021
French biotech raises €5m, looks to restore patient response to anticancer immunotherapies
EverImmune, a biotech based near Paris, and specialized in the development of live biotherapeutic products in the field of microbiota oncology, has raised €5m (US$5.7m) in a Series A funding round from undisclosed private investors.